Market Overview

Medtronic Narrows FY13 EPS Outlook

Related MDT
Oppenheimer: 3 Healthcare Stocks And 2 Energy Stocks To Buy Now
Oppenheimer: Bullish Technical Analysis Of 5 Healthcare Names
Stryker And Osiris Step Into The Bony Void (Seeking Alpha)

In a presentation to investors, Medtronic, Inc. (NYSE: MDT) today updated diluted earnings per share (EPS) guidance for fiscal year 2013.

The Company tightened its fiscal 2013 diluted EPS guidance range to $3.66 to $3.70 from the previously stated range of $3.62 to $3.70. The new range implies annual EPS growth of 6 to 7%.

Posted-In: News Guidance


Related Articles (MDT)

Around the Web, We're Loving...